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Background: Size-specific dose estimate (SSDE), which corrects CT dose index (CTDI) for body
diameter and is a bettermeasure of organ dose than is CTDI, has not yet been validated in vivo.
Objective: The purpose was to determine the correlation between SSDE and measured
breast entrance skin dose (ESD) for pediatric chest CT angiography across a variety of
techniques, scanner models, and patient sizes.
Methods: During 42 examinations done on 4 different scanners over 7 years, we measured
mid-sternal ESD as an approximation of breast dose with skin dosimeters. We recorded
age, weight, effective tube current, kilovoltage potential, console CTDI, and dose-length
product, from which we calculated effective dose. We measured effective chest diameter
to convert CTDI to SSDE, and we correlated SSDE with measured ESD, using linear
regression. We evaluated image quality to answer the clinical question.
Results: Patient mean (SD) age was 8.4  6.1 years (median, 7.9 years; range, 0.02e19.5 years);
mean weight was 35  27 kg (median, 26 kg; range, 3.5e115 kg); effective chest diameter was
20  7 cm (median, 19 cm; range, 10e35 cm). Mean effective dose was 2.9  2.8 mSv (median,
2.2mSv; range, 0.1e14.4mSv).Weobserveda linear correlation (R2¼ 0.98, P< .005) betweenSSDE
(mean, 11  11mGy; median, 7 mGy; range, 0.5e40 mGy) and breast ESD (mean, 12  11 mGy;
median, 7mGy; range, 0.3e44mGy).Ourdoses,whichcompared favorablywith thosepreviously
reported, decreased significantly (P < .05) during the course of our study, because of the intro-
duction of automatic exposure control, low kilovoltage, and high pitch techniques. All studies
were of diagnostic quality.
Conclusion: SSDE is a valid dose measure in children undergoing chest CT angiography over
a wide range of scanner platforms, techniques, and patient sizes, and it may be used to
model breast dose and to document the results of dose reduction strategies.
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J o u r n a l o f C a r d i o v a s c u l a r C om p u t e d T omog r a p h y 8 ( 2 0 1 4 ) 9 7e1 0 7981. Introduction the body, accounting for differences in organ radiosensi-CT angiography (CTA) is increasingly being performed in the
assessment of cardiovascular and coronary abnormalities
in children. Technical advancements in multidetector
CT scanners, such as increased number of detector rows, nar-
rower detector widths, faster gantry revolution time, use of
retrospective electrocardiographic (ECG) gating or prospective
ECG triggering, and dual-source imaging that allow high-pitch
scan acquisitions, have transformed CTA of the chest. These
innovations have led to substantial improvement in image
quality by increasing spatial and temporal resolution and by
reducing motion artifacts.
Concerns about radiation dose associated with radiologic
procedures are growing, and children are at greater risk of
stochastic effect of radiation.1 Although the effective dose (ED)
in a routine pediatric chest CT as measured in an anthropo-
morphic phantom that simulates a 5- to 6-year-old child has
been reported to be in the order of 3 to 7 mSv,2 that of
a retrospectively gated cardiac CTA may as high as 28.5 mSv.3
However, when proper attention is paid to dose reduction
techniques, the dose from chest CTA can compare favorably
with that of typical diagnostic conventional angiography,4,5
which it may replace for several diagnostic indications.6
Several dosimetry measures have been used to characterize
dose during chest CTA7,8:
1. The dose parameters as they are now routinely displayed
on scanner consoles include volume CT dose index
(CTDIvol) and dose-length product (DLP), which are based
on measurements in standard CT dose phantoms of
either 16 or 32 cm in diameter. In children, who have
a wide range of body diameters that are not accurately
predicted by either age or body weight,9 these CT dose
descriptors are unreliable.10 Recently, the American
Association of Physicists in Medicine in its Task Group
204 Report (AAPM-TG204)11 described the calculation of
size-specific conversion of scanner console CTDIvol as
a more accurate descriptor of absorbed dose in patients
with a variety of body habitus, including children. A
recent study has shown this measure to be the most
accurate when both the anteroposterior (AP) and trans-
verse or lateral (LAT) body dimension are taken into
account.12
2. The absorbed dose in various organs is another dosimetry
measure. In chest CTA, the most exposed radiosensitive
organs are the breast and lung.13 In breast tissue, a direct
link between diagnostic radiation at a young age and
induction of cancer has been strongly suggested.14,15
Breast dose can be calculated through computer
modeling16,17 or directlymeasured only with the use of an
anthropomorphic phantom.18,19 However, in prepubertal
children whose breasts have not yet developed and dose
distribution is relatively uniform in the scanned body
parts,20 the breast dose may simply be equated to
entrance skin dose (ESD), which can bemeasured directly.
3. The ED, as defined in the publications of the International
Commission on Radiological Protection,21,22 is the
weighted sum of doses absorbed in all exposed organs intivity, and is calculated in phantoms or computer models
that represent the adult human body. Although ED is
thought to correlate best with overall stochastic radiation
risk, it is not an actual dose received by any person, and
absorbed dose values in the exposed organs are required
to better estimate individual radiation risks.18,23e25 ED,
even when calculated correctly by taking pediatric body
size and age into consideration,26 still contains a large
margin of error when attempting to estimate individual
cancer risk.18,24,25,27,28
4. For simplicity and comparison purposes, it has become
customary to express dose in terms of the equivalent of
number of months (or years) of natural background
radiation, maximum annual occupational dose, number
of chest radiographs, and so forth. Because the breast is
a critical organ in chest CTA, for which radiation dose can
be measured directly in young children, we decided to
express breast organ dose in terms of the number of adult
single view mammograms that would result in an equal
breast dose as the CTA examination (mammogram
equivalent dose, MED).
Prior studies of pediatric chest CTA dose have been per-
formed in phantoms only2,3,29 or have erroneously relied only
on manufacturer-provided radiation dose measures (CTDIvol
and DLP).6 To the best of our knowledge, direct measurement
of ESD during pediatric chest CTA examinations has not been
described. The purpose of our study was to use measured ESD
to validate SSDE (calculated from console-displayed CTDIvol)
and to estimate breast dose and ED, as a function of scanning
technique and patient factors.2. Methods
2.1. Patients
This studywas approved by our institutional review boardwith
a waiver of written informed consent. The cohort of this
prospective observational study comprised 40 consecutive
children (male-to-female ratio, 3:1; age range, 6 days to
19.5 years; mean age, 8.4  6.1 years; weight range, 3.5e115 kg;
mean weight, 34.6 kg) who were referred for chest CTA from
March 2004 to April 2011. The clinical indications ranged from
evaluation for cyanotic heart disease (12 patients), acyanotic
heartdisease (7patients), cardiomediastinal tumors (2patients),
and abnormalities of the thoracic aorta (9 patients), coronary
arteries (9 patients), and pulmonary arteries (1 patient). Two
patients had chest CTA performed twice within the study
period, and both examinationswere included in the study (total
chest CTA examinations, 42).
2.2. Scanning protocols
In this study, all patients were scanned with parameters that
were judged by the executing radiologist to be appropriate
to address the clinical indication while minimizing radiation
dose, without an a priori aim to standardize protocols. Each
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scanners: 16 detector rows (Somatom Sensation 16; Siemens
Medical Solutions, Forchheim, Germany; n ¼ 4; 2004),
32 detector rows (Somatom Sensation 64; Siemens Medical
Solutions; n ¼ 15; 2005e2007), dual source (Somatom Defini-
tion; Siemens Medical Solutions; n ¼ 13; 2009), and high-pitch
dual source (Definition Flash; Siemens Medical Solutions;
n ¼ 10; 2010e2012). The Sensation 64 and Definition scanners
use 32 detector rows with flying focal spot scanning tech-
nique, effectively doubling the number of detector rows to 64,
and the Definition Flash scanner uses 64 detector rows with
flying focal spot (effectively 128 rows). Both gated (n ¼ 18) and
nongated (n ¼ 24) chest CTA examinations were performed.
The patients were scanned at their normal heart rate, and
heart rate-controlling agents were not used. Retrospective
gating was performed in 17 examinations, with ECG-
synchronized tube current modulation at the 65% ReR
interval, and prospective ECG triggering was performed in 1
examination. All 24 nongated and 5 of the 18 gated chest CTAs
were performed with combined longitudinal and transverse
automatic exposure control (Care-dose 4D; Siemens Medical
Solutions).30e32 In children who weighed <40 kg, the applica-
tion of this technique requires users to specify a reference
tube current-time product value for a “reference” 20-kg child;
the system then adjusts the tube current according to patient
size. The strength of modulation was set as weak decrease for
subjects smaller than the reference child and weak increase
for subjects larger than the reference child. In children who
weighed >40 kg, the adult Care-dose 4D settings were chosen.
Each patient received 2 mL/kg of a nonionic contrast
medium (Isovue 370; Bracco Diagnostics, Princeton, NJ)
infused through a 20- to 22-gauge intravenous antecubital
catheter. The injection rate was adapted to the patient’s age
and available intravenous access. In young children, scanning
was started 10 to 15 seconds after the beginning of the injec-
tion. For coronary CTA in patients older than 10 years, we used
a timing bolus technique to determine scan delay from the
start of injection. Three-dimensional images were recon-
structed on a Siemens 3D workstation (Leonardo/Syngo;
Siemens Medical Solutions).Table 1 e Conversion k-factors from DLP (in reference to
a 32-cm CT dose phantom) to effective dose, as a function
of age.
Age group Age
assignment10
k-Factor
(32-cm phantom)33
mSv/mGy  cm
80 kVp 100 kVp 120 kVp
Newborn to 3 mo 0 year old 0.0823 0.0739 0.0706
4 mo to 2 y 11 mo 1 year old 0.0525 0.0480 0.0467
3 y to 7 y 11 mo 5 year old 0.0344 0.0322 0.0314
8 y to 14 y 11 mo 10 year old 0.0248 0.0235 0.0234
15 y and older Young adult 0.0147 0.0144 0.0145
DLP, dose-length product.2.3. Radiation dose measurements
During all chest CTA examinations, ESD of the exposed breast
area was directly measured with the Unfors skin dosimeter
(Unfors model TN-RD-60, Billdal, Sweden). The Unfors skin
dosimetry device is equipped with 3 dose detectors, which
were placed in the axial plane through the chest that inter-
sected with both nipples in the following standard 3 locations:
right nipple, mid-sternum, and left nipple. The dosimeters
were placed after the preparatory scans (scout views, timing
bolus [if any]), so as to onlymeasure the dose of the diagnostic
portion of the scan. Ratios of themeasured surface doses over
both nipples (breast dose) to mid-sternal ESD were recorded,
and their means and standard deviations were calculated. We
also expressed these values in terms of number of adult single
view MEDs, which carry an organ dose of 1.5 mGy per view at
our institution, based on an assumed 4.5-cm compressed
breast thickness imaged on a digital mammography unit.2.4. Scan parameters and radiation dose recordings
from scanner console
In each examination, we recorded the following scan
parameters: effective tube current-time product (in mAs),
kilovoltage potential, pitch, the CTDIvol, 32cm and DLP32cm,
whichwere routinely reported in reference to a 32-cmCT dose
phantom on our scanner console in our study by using body
protocols. We recorded the following patient parameters: sex,
age, and weight.
2.5. Calculation of SSDE
For each scan, we measured with on-screen calipers in
centimeters the maximum AP dimension of the chest on
a standard axial image through the left inferior pulmonary
vein. Because this image, given the used display field of view,
did not always include the entire transverse dimension (LAT)
of the chest, we measured this on the scanogram at the same
longitudinal position as the standard axial image, bymeans of
the cross-reference tool on our picture archival and commu-
nication system. According to AAPM-TG204, we calculated the
effective chest diameters as the square root of the product of
AP and LAT, and converted CTDIvol, 32cm to SSDE values, using
the conversion factors listed in Table 1 of the AAPM-TG204
publication.11
2.6. Calculation of ED
We calculated ED on the basis of the most recently published
age- and kilovoltage potential-adjusted DLP32cm -to-ED conver-
sion k-factors33 (Table 1), which are in turn based on the tissue
weighting factors used in the most recent publication from the
International Commission on Radiological Protection.22
2.7. Image analysis
Two cardiac radiologists (S.J.W and M.K.K.) independently
evaluated image quality in terms of subjective image noise,
artifacts, visibility of small structures, and diagnostic accept-
ability for pulmonary vessels, coronary arteries, and branches,
as well as cardiac chambers.
We graded subjective image noise on a 5-point scale that
was based on presence and amount of image mottle or
J o u r n a l o f C a r d i o v a s c u l a r C om p u t e d T omog r a p h y 8 ( 2 0 1 4 ) 9 7e1 0 7100graininess (1 ¼ minimal image noise, 2 ¼ less than average
noise, 3 ¼ average image noise, 4 ¼ above average noise,
5¼unacceptable imagenoise).Wegradedthevisibilityof small
structureswith theuseof a5-point scale,witha scoreof 1being
excellent visualization and 5 being unacceptable visualization
of small structures. We graded beam hardening or streak
artifacts on a 5-point scale, with score of 1 being artifacts
affecting the interpretation of lesion or organ of interest and 5
being complete absence of artifacts. We evaluated diagnostic
acceptability for clinical interpretation on a 4-point scale,
which included fully acceptable (grade 1), probably acceptable
(grade 2), acceptable only in limited condition (grade 3), and
diagnostically unacceptable (grade 4).2.8. Statistical analysis
Relationships between 2 variables were assessed with the
Spearman rank correlation test, the Spearman r and P value.
With this test, rank correlations are not easily influenced by
outliers in the data. Linear regression analysis was applied to
comparable dose measures, with calculation of the coefficient
of determination (R2). The y-intercept was constrained to be
zero, and the slopes of the regression lines were calculated,
with 95% CIs.3. Results
3.1. Conversion of scanner console CTDIvol, 32cm to SSDE
The mean (SD) SSDEs for the scans of our study group were
21.1  11.9 mGy (median, 16.7 mGy; range, 4.0e40.3 mGy) for
retrospective gating (n ¼ 17), 6.5 mGy for prospective gating
(n ¼ 1), 4.6  3.8 mGy (median, 3.9 mGy; range, 0.5e16.4 mGy)
for nongated examinations (n ¼ 24), 18.5  12.0 mGy (median,
16.0 mGy; range, 4.1e40.3 mGy) for Sensation 16e64 (n ¼ 19),
and 5.4  6.6 mGy (median, 3.7 mGy; range, 0.5e32.1 mGy) for
Definition and Flash (n ¼ 23).3.2. Measured dose: mid-sternal ESD
3.2.1. Effect of scanner type
We measured the following ESD values on the Sensation 16
(mean, 12.6  4.3 mGy; median, 12.5 mGy; range, 8.4e17.2 mGy;
n ¼ 4), Sensation 64 (mean, 20.5  13.1 mGy; median, 16.8 mGy;
range,3.2e44.2mGy;n¼15),SomatomDefinition (mean,7.98.3
mGy; median, 4.8 mGy; range, 1.0e31.5 mGy; n ¼ 13), and Defi-
nition Flash CT scanners (mean, 3.6 2.2mGy;median, 3.8mGy;
range, 0.3e6.9 mGy; n ¼ 10). A statistically significant (P < .05)
decreasewas observed in ESDvalues of studies performedon the
Definition scanner comparedwith the Sensation 64 scanner and
also of studies performed on the Flash scanner compared with
the Definition scanner.
3.2.2. Effect of scan protocol
The mean ESD was 21.4  11.8 mGy (median, 16.8 mGy; range,
5.7e44.2 mGy) for retrospective gating (n ¼ 17), 9.8 mGy for
prospective gating (n¼ 1), and 5.1  4.6 mGy (median, 4.3 mGy;
range, 0.3e21.7 mGy) for nongated examinations (n ¼ 24).3.3. Correlation and linear regression of console CTDIvol,
32cm, before and after size correction (to SSDE), with
measured mid-sternal ESD
Whereas we found a significant rank correlation and linear
regression between console CTDIvol, 32cm and mid-sternal ESD
(Fig. 1A; r ¼ 0.96, P < .001, R2 ¼ 0.91; slope, 1.55 [95% CI,
1.42e1.68]), the correlation improved further after size correc-
tion of CTDIvol, 32cm to SSDE (Fig. 1B; r¼ 0.96, P< .001, R2¼ 0.96;
slope, 1.01 [95%CI, 0.97e1.06]). Considering that the slope of the
linear regression line of ESD vs console CTDIvol, 32cm is unduly
decreased by our highest recorded ESD value (44.2 mGy), it can
be seen that on average console CTDIvol, 32cm underestimated
measured absorbed breast dose (ESD) by approximately 60%.
However, especially in younger children, individual ratios
between measured dose ESD and console CTDIvol, 32cm were
much higher, up to 3.5.
3.4. Breast dose
Calculated median ratios between measured mid-sternal ESD
divided by right and left breast ESD, respectively, were 1.03
(range, 0.80e1.85) and 1.02 (range, 0.56e1.67). The number of
single mammogram views equivalent in dose to mid-sternal
ESD (MED) varied greatly across our study population
(Table 2; from 0.67 to 29.5 MEDs, by a factor of 44), because of
our marked variability in patient size, weight, and chosen
technical scan parameters.
Representative examples of the wide range of exposure
factors and scan techniques that were used in our diverse
patient population, with resulting image quality, are shown
in Figs. 2 to 4. For instance, the ESD for coronary CTA varied
between 9.8 and 44.2 mGy, equivalent to 6.5 to 25.5 mammo-
grams, respectively, by a factor of >4, depending on the kilo-
voltage potential, tube current-time product, and gatingmode
that was chosen and on whether Care-dose 4D was used
(Figs. 3 and 4).
3.5. Pediatric ED
3.5.1. Effect of scanning protocol
The calculated pediatric mean ED was 4.8  3.4 mSv (median,
4.0 mSv; range, 0.7e14.4 mSv) for retrospective gating (n ¼ 17),
1.0 mSv for prospective gating (n ¼ 1), and 1.7  1.3 mSv
(median, 1.5 mSv; range, 0.1e4.9 mSv) for nongated exami-
nations (n ¼ 24).
3.5.2. Effect of patient factors (age, weight, diameter)
On average, the highest ED values were calculated in the 3- to
8-year age group (Table 2). We observed no correlation of ED
with weight or diameters (R2 ¼ 0.11e0.31).
3.6. Image quality evaluation
Neither of the 2 radiologists rated any of the 42 pediatric chest
CTA examinations as unacceptable for subjective image noise.
Likewise, both radiologists found image contrast to be
acceptable in all patients. Although 2 of the 42 CT examina-
tions had pronounced artifacts from ECG leads, the remaining
CT examinations had little or no artifacts. In none of the scans
Fig. 1 e Graphs show the linear regression of ESD as
a function of console CTDIvol, 32cm (A) and SSDE (B). Note
the improved linear correlation between ESD and CTDI
after size correction to SSDE from A to B. The scanner
model for each data point is indicated in the color key.
Note the overall downward trend in doses from 2005
(Sensation 64) through the present (Definition Flash).
CTDIvol, 32cm, volume CT dose index in standard CT dose
phantom of 32 cm; ESD, entrance skin dose; SSDE, size-
specific dose estimate.
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J o u r n a l o f C a r d i o v a s c u l a r Com p u t e d T omog r a p h y 8 ( 2 0 1 4 ) 9 7e1 0 7 101did the placement of the skin dosimeters interfere with
diagnostic image quality. Diagnostic information essential to
answering the clinical question(s) could be obtained in all
42 examinations. Both radiologists rated the visibility of the
aorta, pulmonary arteries and their branches, the cardiac
Fig. 2 e Six-day-old 3.5-kg male newborn evaluated for
pulmonary atresia and multiple aortopulmonary collateral
arteries in 2006. Axial (A), coronal (B), and shaded surface
rendition (C) images of nongated CTA (Somaton Sensation
64, use of Caredose 4D) show diagnostic image quality
to assess pulmonary arterial anatomy. Study was done
at 80 kVp and 77 mAeff, console CTDIvol, 32cm [ 1.6 mGy,
J o u r n a l o f C a r d i o v a s c u l a r C om p u t e d T omog r a p h y 8 ( 2 0 1 4 ) 9 7e1 0 7102chambers, and the origins of the coronary arteries as satis-
factory to excellent. They rated overall diagnostic accept-
ability as unacceptable only for the peripheral branches of the
coronary arteries in 11 of the 42 CT examinations, all of which
were not specifically performed to assess the coronary
arteries. Neither radiologist gave unacceptable scores for
pulmonary arteries and cardiac chambers on any study.4. Discussion
Ours is the first study to perform intraprocedural measure-
ments of breast ESD frompediatric chest CTA. As expected, the
main technical parameters that influenced ESD were
kilovoltage and effective tube current-time product. Retro-
spective gating resulted in a relatively high ESD, on average
4 times higher than our single observation of dose in
aprospectively triggeredCTAstudy and 2 to 3 timeshigher than
the nongated studies. Our ESD measurements confirmed the
fact that scanner console-displayed CTDIvol, 32cm can underes-
timate absorbed dose in young children by a factor of up
to 3.5.11,12 This reemphasizes the need to apply correction
factors to scanner console-providedCTDIdatawhenestimating
organ doses, especially in young children.10,34,35 Some scanner
manufacturers have provided conversion factors between
CTDIvol, 32cm values, which are typically displayed on the
console during body imaging acquisitions, and CTDIvol, 16cm
values, which are presumed to better represent the dose to
youngchildren.However, this is still a crudeway to characterize
pediatric dose, because only 2patient diameters are recognized:
16 and 32 cm.12 According to AAPM-TG20411 and its recent
arithmetic validation study,12 the most reliable correction to
scanner console CTDIvol is done with a continuous scale that
factors in the marked variations of cross-sectional body diam-
eter that exist in the pediatric age group,9 throughcalculation of
SSDE, a new dose metric that was developed in vitro through
phantom studies and computer modeling, and that is not
primarily determined by patient age or weight. Over a wide
range of patient factors, scanning techniques, and scanner
platforms, our study provides a solid and independent in vivo
validation of the SSDE concept. Recent studies add support to
the fact that SSDEwill also be able to predict doses to the deeper
organs (suchas the lungs) that arenot amenable todirect invivo
measurement and also those organs located at different z-axis
positions (including those in the abdomen).13,17,35
The way we used our ESD measurements to model breast
dose has a number of limitations. First, measured skin dose
depends on the proximity of the skin dosimeter in the scanner
gantry to the x-ray source, that is influenced by cross-
sectional body diameter and the correct centering of the
patient, and we did not correct for these factors. Second, ESDSSDE [ 4.3 mGy, ESD [ 3.2 mGy (equivalent to 2
mammograms), DLP [ 19 mGy 3 cm, calculated pediatric
ED22 [ 1.6 mSv. CTA, CT angiography; CTDIvol, 32cm,
volume CT dose index in standard CT dose phantom of 32
cm; DLP, dose-length product; ED, effective dose; ESD,
entrance skin dose; mAeff, effective tube current; SSDE,
size-specific dose estimate.
Fig. 3 e Fourteen-year-old 115-kg obese boy evaluated for atypical chest pain, to rule out coronary artery disease in 2006.
Curved reformatted image of right coronary (A) and shaded surface rendition (B) of retrospectively gated CTA (Somaton
Sensation 64, no use of Care-dose 4D) show diagnostic image quality (rated grade 2, probably acceptable) to assess the
coronary arteries, which were found to be normal. Study was done at 120 kVp and 850 mAeff, console CTDIvol, 32cm [ 37.9
mGy, SSDE [ 39.8 mGy, ESD [ 44.2 mGy (equivalent to 25 mammograms), DLP [ 485 mGy 3 cm, calculated ED22 [ 11.4
mSv. CTA, CT angiography; CTDIvol, 32cm, volume CT dose index in standard CT dose phantom of 32 cm; DLP, dose-length
product; ED, effective dose; ESD, entrance skin dose; mAeff, effective tube current; RCA, right coronary artery; SSDE, size-
specific dose estimate.
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Fig. 4 e Seventeen-year-old 64-kg boy, evaluated for
atypical chest pain to rule out coronary artery disease in
2008. Curved reformatted image of right coronary (A) and
shaded surface rendition (B) of prospectively triggered CTA
(Somaton Definition, use of Care-dose 4D) show diagnostic
image quality (rated grade 1, fully acceptable) to assess the
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with no developed breast tissue, but less so in female
adolescents in whom there is more attenuation of the beam at
the level of the radiosensitive glandular breast tissue. The
contribution of scatter radiation to breast dose will be
different in undeveloped vs fully developed breasts, and we
have not accounted for this. Third, the clinical rationale of
comparing the estimated absorbed dose in the undeveloped
breast in young children, including boys, with that imparted
by a mammogram in adult women may be questioned.
Although we expressed ESD in terms of equivalent number of
mammogram views (MED), based on a typical single
mammogram view dose of 1.5 mGy at our institution, in
actuality the dose per view from mammography can vary
considerably, depending on equipment used (digital vs
analog) and compressed breast thickness. Of course, this
limitation applies similarly to other qualitative equivalent
dose comparison measures that are in use, such as measures
that use natural background radiation or number of chest
radiographs. Finally, our simplification to equate breast ESD
to mid-sternal ESD introduced errors. Overall, we found that
measurement of mid-sternal ESD systematically over-
estimated breast ESD by approximately 2% to 3%. This
difference is of much less importance than fluctuations in
dose within the axial plane as a result of the transverse dose
modulation function that is part of Siemens Care-dose 4D, and
is also greatly influenced by the tube current modulation in
ECG-gated studies, as is reflected in the marked individual
interscan variation of the ratio between breast and mid-
sternal ESD that we found with the Unfors skin dosimeters.
Given all these uncertainties in our characterization of breast
dose and its clinical significance, we do not claim that we can
estimate breast cancer risk in individual patients from our
data. Aware of these limitations, we merely present our MED
calculations here for illustration purposes, in a similar fashion
as other investigators have, when expressing dose in terms of
an equivalent number of chest radiographs or time period
of exposure to natural background radiation.
The k-factors for converting DLP to pediatric ED increase
with younger age.33,36 These ED calculations that are based
on k-factors are still only rough estimates of patient-specific
ED, because they do not account for variability of cross-
sectional diameter as a function of age.37 For this, time-
consuming patient size-adjusted Monte Carlo computer
simulations in combination with phantom measurements
would be required, and our data acquisition protocol did notcoronary arteries, which were found to be normal. Study
was done at 100 kVp and 151 mAeff, console CTDIvol, 32cm[
5.1 mGy, SSDE [ 6.5 mGy, ESD [ 9.8 mGy (equivalent to
6.5 mammograms), DLP[ 68 mGy 3 cm, calculated ED22[
1.0 mSv. Note the better image quality of this study
compared with the one illustrated in Fig. 3, despite the
substantially lower radiation dose. CTA, CT angiography;
CTDIvol, 32cm, volume CT dose index in standard CT dose
phantom of 32 cm; DLP, dose-length product; ED, effective
dose; ESD, entrance skin dose; mAeff, effective tube current;
RCA, right coronary artery; SSDE, size-specific dose
estimate.
Table 3 e Comparison of our pediatric cardiac CTA effective and breast dose values with others published in the literature.
Study examination type Study type, age Scanner type* No. Tube potential (kVp) ED (mSv)22 Breast dose (mGy)
This study chest CTA Series
8.4  6.1 y [6 d to 19.5 y]
Sensation 16 1 80 .0  1.0y [2.2e4.0] 12.6  4.3 [8.4e17.2]
3 100
Sensation 64 7 80  3.8 y,z [1.6e14.4] 20.5  13.1 [3.2e44.2]
7 100
1 120
Somaton Definition 10 80  1.7 y,z [0.4e5.6] 7.9  8.3 [1.0e31.5]
3 100
Definition Flash 6 80 .9  0.8x [0.1e2.4] 3.6  2.2 [0.3e6.9]
3 100
1 120
Hollingsworth et al3 cardiac CTA Phantom (5 y) GE Lightspeed 120 [17.2e19.9]y [34e120]
Huang et al29 coronary CTA Phantom (5 y) GE Discovery 100 [11.8e16.5]z NA
Herzog et al38 cardiac CTA Series 5.8 y [1 d to 15 y] GE Lightspeed 30 120 4.4  2.1z NA
Sensation 64 12 120 7.3  2.6z NA
Sensation 64 38 80e120 2.5  2.1z NA
Lee et al6 cardiac CTA Series < 1 mo Philips Brilliance 4 80 3.9  0.5z NA
Philips Brilliance 10 120 11.4  2.5z NA
Ben Saad et al34 cardiac CTA Series < 1 y Definition 78 80 0.5  0.2z NA
Definition 32 80 1.3  0.6y NA
Kuettner et al39 cardiac CTA Series < 1 mo Definition 12 80e100 [0.6e3.2]y,{ NA
Goo and Yang43 coronary CTA Series 5 mo (1 d to 6 y) Definition 108 80 0.36  0.12jj NA
Paul et al40 coronary CTA Series 1.2 y [9 d to 5.4 y] Definition Flash 30 80 0 6  0.16jj [0.05e0.8] NA
Lell et al41 chest CT Series 14  17 mo Definition Flash 30 80 1.9  0.5x NA
Han et al42 cardiac CTA Series < 2 y Toshiba Aquilon 29 80 2.1 [1.1e10.6]z NA
Definition Flash 32 80 0.29 [0.1e1.9]x NA
Fujii et al2 chest CT Phantom (6 y) Sensation 16 120 1.3z 2.0
Sensation 64 120 7.4z 17.1
Shrimpton36 Chest CT Population survey Various NA (0e1 y) 6.3z 11**
NA (5 y) 3.6z 11**
NA (10 y) 3.9z 14**
CTA, CT angiography; CTDIvol, volume CT dose index; ED, effective dose; NA, information not available.
Values are indicated as means  SD and [range] when available; if no standard deviations were reported, [ranges] or mean values are indicated.
* Unless specified otherwise, listed scanner manufacturer is Siemens (Siemens Medical Solutions, Forchheim, Germany); GE is General Electr Healthcare Inc, Milwaukee WI; Philips is Philips
Healthcare, Best, The Netherlands; Toshiba is Toshiba America Medical Systems Inc, Tustin CA.
y Retrospectively gated studies.
z Nongated studies.
x High-pitch studies (pitch  2.25).
{ Reported dose range are values that the investigators state are “possible” on the basis of retrospective analysis of potential for further dose red tion in 6 of their 12 patients; they are not actually
obtained values.
jj Prospectively triggered studies (“step and go”).
** Reported values are CTDIvol, 16 cm , as a rough indicator of breast dose.
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correcting DLP for individual body size as a basis to calculate
individual ED values with the use of the k-factors.11 Thus, our
current inability to calculate individual size-adjusted ED in
a simplified manner from scanner console dose data consti-
tutes a substantial limitation to attempts at predicting indi-
vidual cancer risk from CT radiation in children, if this is
possible at all.18,24,25,27,28 To compare our ED values with
those reported in the literature (Table 3), which were mainly
calculated with the k-factors by Shrimpton et al,36 one has to
realize that the newest ED estimates based on the k-factors
by Deak et al33 are lower by approximately 10% for the same
scan settings.26
No study of CT radiation dose would be complete without
considering image quality at the same time. With our study,
we did not characterize image quality through objective
measurements of image noise, as others have done, because
this measure is compounded by the variety of reconstruction
kernels we used for image reconstruction, as well as by the
large variability of other confounding variables in our study,
both patient and technique related. Image noise has
a complex relationship with dose, especially in retrospective
image reconstruction; exposure takes place during the entire
cardiac cycle, but only a portion of the data is used for image
reconstruction. Whereas dose is accumulated during the
entire CT scan, only the portion that is used in image recon-
struction affects the noise. We did not find that noise as
subjectively rated by our image reviewerswas a limiting factor
at the interpretation of any of our studies. This reaffirms that
for CT angiography of the chest, because of a high intrinsic
contrast-to-noise ratio, dose can be reduced more aggres-
sively than in other imaging tasks that are more challenging
because of a low contrast-to-noise ratio, such as brain and
liver imaging. The limitations we encountered in coronary
imaging are more because of a lack of temporal resolution in
our nongated studies, leading to motion unsharpness, rather
than noise being the limiting factor. Factors that determine
the quality of a chest CTA to amuch greater extent than image
noise are the degree of contrast enhancement of the vascu-
lature of interest and the efficiency of our strategies used to
reduce motion: cardiac gating and high-pitch scanning
techniques.
Ours is a single-center study with a relatively small sample
size. The fact that we observed and compared highly variable
techniques over a relatively long time period may be regarded
both as a weakness and a strength. We were able to show that
the novel concept of SSDE as the proposed best available
absorbeddoseparameter for pediatricCTholds trueover awide
variety of patient factors and scanning techniques. Our
prospective study was merely observational, without system-
atic efforts to intervene and optimize the balance between dose
and image quality. However, over our prolonged study period,
technical advances have allowed us to reduce dose by an order
of magnitude of 10 or more, with preservation of diagnostic
image quality. In particular, high pitch reduced kilovoltage
scanning, and the use of automated exposure control has
recently reduced dose values from pediatric chest CTA to well
below 1 mSv, and the increased acquisition speed of the
examination has reduced the need for high-dose retrospective
cardiac gating and sedation to optimally image the coronaryarteries. This downward trend inpediatric chest CTAdoses also
can be observed in other studies reported in the literature over
time2,3,6,29,34,36,38e43 (Table 3), with which our dose values
compare favorably. Despite the limitations of our study, as
detailedabove,webelieve that it representsour best estimate of
the breast and effective doses our patients received from chest
CTA, information that can be used in future studies to balance
the radiation risk with the diagnostic benefit in children. We
believe that, with the application of novel iterative image
reconstruction techniques,more profound dose reductionwith
preservation of image quality is possible than is shown here.44
Our study reemphasizes the need for manufacturers
to report pediatric dose data in a more consistent and trans-
parent manner that is more easily applicable to children of
various ages and body sizes, to allow doseeefficiency compar-
isons between various scanner types and manufacturers and,
eventually, to facilitate optimization of the balance between
radiation dose and image quality in pediatric chest CTA.5. Conclusion
SSDE is a valid measure of CT dose in children undergoing
chest CTA over awide range of scanner platforms, techniques,
and patient sizes andmay be used tomodel breast dose and to
document the results of dose reduction strategies.r e f e r e n c e s
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